Multi-modal neo-adjuvant anti-obesity medications may be more effective than medically supervised weight loss or GLP-1 therapy alone in preparing BMI≥70 patients for metabolic surgery.

Saved in:
Bibliographic Details
Title: Multi-modal neo-adjuvant anti-obesity medications may be more effective than medically supervised weight loss or GLP-1 therapy alone in preparing BMI≥70 patients for metabolic surgery.
Authors: Kachmar M; Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA, USA.; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Our Lady of the Lake, Franciscan Missionaries of Our Lady Health System, Baton Rouge, LA, USA., Corpodean F; Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA, USA.; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Popiv I; Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA, USA.; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., LaPenna KB; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Danos DM; Department of Behavioral & Community Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Cook MW; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; University Medical Center, New Orleans, LA, USA., Saunders BA; Our Lady of the Lake, Franciscan Missionaries of Our Lady Health System, Baton Rouge, LA, USA.; Metamor™ Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, LA, USA., Domercant JJ; Our Lady of the Lake, Franciscan Missionaries of Our Lady Health System, Baton Rouge, LA, USA.; Metamor™ Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, LA, USA., Albaugh VL; Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA, USA.; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA.; Our Lady of the Lake, Franciscan Missionaries of Our Lady Health System, Baton Rouge, LA, USA.; Metamor™ Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, LA, USA., Schauer PR; Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, LA, USA. philip.schauer@pbrc.edu.; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA. philip.schauer@pbrc.edu.; Our Lady of the Lake, Franciscan Missionaries of Our Lady Health System, Baton Rouge, LA, USA. philip.schauer@pbrc.edu.; Metamor™ Metabolic Institute, Pennington Biomedical Research Center, Baton Rouge, LA, USA. philip.schauer@pbrc.edu.
Source: International journal of obesity (2005) [Int J Obes (Lond)] 2025 Aug; Vol. 49 (8), pp. 1516-1522. Date of Electronic Publication: 2025 Jun 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5497 (Electronic) Linking ISSN: 03070565 NLM ISO Abbreviation: Int J Obes (Lond) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5497
DOI:10.1038/s41366-025-01798-2